Directory
Portfolio companies.
34,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
8
currently held
Exits tracked
5
hand-checked
Sectors covered
1
across the portfolio
Countries covered
1
from every market
Latest activity
Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capitalCaledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capitalCaledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capital
Elaia PartnersadminCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway2 weeks agoCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway
adminLauxera Capital PartnersadminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board1 month agoBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board
admin12 companies matching
| Company | Sector | Geo | Investor | Entry | Hold | Status | Buyer | MOIC | |
|---|---|---|---|---|---|---|---|---|---|
Aidian2 periods Nordstjernan | Nordstjernan | 2018 | 4yr | Active | – | – | |||
Blueprint Genetics Creathor Venture Fund III | Creathor Ventures | 2017 | 3yr | Exited 2020 | Quest Diagnostics | – | |||
Synoste Evonik Venture Capital | Evonik Venture Capital | 2015 | 5yr | Exited 2020 | Globus Medical | – | |||
Optomed Robert Bosch Venture Capital Fund III | Bosch Ventures | 2015 | 4yr | Exited 2019 | – | – | |||
Palodex Altor Fund I | Altor Equity Partners | 2005 | 4yr | Exited 2009 | Danaher | – | |||
Serres G Square Capital IV | G Square Healthcare PE | 2026 | 0yr | Active | – | – | |||
Taika 3D Nina Capital Fund II | Nina Capital | 2022 | 4yr | Active | – | – | |||
IXI2 periods byFounders II | byFounders | 2022 | 4yr | Active | – | – | |||
Pixieray2 periods Nordic Secondary Fund I | Nordic Secondary Fund | 2022 | 4yr | Active | – | – | |||
CurifyLabs HealthCap VIII | HealthCap | 2026 | 0yr | Active | – | – | |||
Maculaser ZEISS Ventures CVC | ZEISS Ventures | 2026 | 0yr | Active | – | – | |||
Surgify Medical ZEISS Ventures CVC | ZEISS Ventures | 2025 | 1yr | Active | – | – |
Aidian
Nordstjernan
FinlandSector
MedTech
InvestorNordstjernan
Entry
2018
Hold
4yr
Owners
2
Blueprint Genetics
Creathor Venture Fund III
FinlandSector
MedTech
InvestorCreathor Ventures
Entry
2017
Hold
3yr
Exit
2020
to Quest Diagnostics
Synoste
Evonik Venture Capital
FinlandSector
MedTech
InvestorEvonik Venture Capital
Entry
2015
Hold
5yr
Exit
2020
to Globus Medical
Optomed
Robert Bosch Venture Capital Fund III
FinlandSector
MedTech
InvestorBosch Ventures
Entry
2015
Hold
4yr
Exit
2019
Palodex
Altor Fund I
FinlandSector
MedTech
InvestorAltor Equity Partners
Entry
2005
Hold
4yr
Exit
2009
to Danaher
Serres
G Square Capital IV
FinlandSector
MedTech
InvestorG Square Healthcare PE
Entry
2026
Hold
0yr
Taika 3D
Nina Capital Fund II
FinlandSector
MedTech
InvestorNina Capital
Entry
2022
Hold
4yr
IXI
byFounders II
FinlandSector
MedTech
InvestorbyFounders
Entry
2022
Hold
4yr
Owners
2
Pixieray
Nordic Secondary Fund I
FinlandSector
MedTech
InvestorNordic Secondary Fund
Entry
2022
Hold
4yr
Owners
2
CurifyLabs
HealthCap VIII
FinlandSector
MedTech
InvestorHealthCap
Entry
2026
Hold
0yr
Maculaser
ZEISS Ventures CVC
FinlandSector
MedTech
InvestorZEISS Ventures
Entry
2026
Hold
0yr
Surgify Medical
ZEISS Ventures CVC
FinlandSector
MedTech
InvestorZEISS Ventures
Entry
2025
Hold
1yr